• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to 4-(3-Phenylpropoxy)piperidine Hydrochloride (CAS No. 745066-62-0)

4-(3-Phenylpropoxy)piperidine hydrochloride, identified by its Chemical Abstracts Service (CAS) number 745066-62-0, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This piperidine derivative features a phenylpropoxy side chain, which contributes to its unique pharmacological properties and potential applications in drug development. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and a candidate for further exploration in therapeutic contexts.

The molecular structure of 4-(3-Phenylpropoxy)piperidine hydrochloride consists of a piperidine ring substituted with a 3-phenylpropoxy group, linked via an N-O bond to the nitrogen atom of the piperidine core. This configuration imparts specific steric and electronic characteristics that influence its interactions with biological targets. The presence of the phenyl group and the propoxy moiety creates a balance between lipophilicity and polarizability, which is critical for drug-like properties such as bioavailability, metabolic stability, and binding affinity.

In recent years, there has been growing interest in piperidine derivatives due to their role as key scaffolds in the design of central nervous system (CNS) drugs. The structural motif of 4-(3-Phenylpropoxy)piperidine hydrochloride aligns well with this trend, as it shares similarities with known pharmacophores found in psychoactive substances and potential therapeutic agents. Research has demonstrated that modifications at the piperidine ring and the attached substituents can significantly alter pharmacological activity, making this compound a promising candidate for further investigation.

One of the most compelling aspects of 4-(3-Phenylpropoxy)piperidine hydrochloride is its potential as a precursor in the synthesis of more complex molecules. Its versatile structure allows for easy functionalization at multiple sites, enabling chemists to explore diverse chemical libraries. This flexibility is particularly valuable in high-throughput screening (HTS) campaigns, where rapid synthesis and modification of compounds are essential for identifying novel drug candidates.

Recent studies have highlighted the importance of optimizing solubility and pharmacokinetic profiles in drug development. The hydrochloride salt form of 4-(3-Phenylpropoxy)piperidine hydrochloride offers improved solubility compared to its free base form, which can enhance oral bioavailability and reduce dosing requirements. This property is particularly relevant in formulations designed for systemic delivery, where solubility plays a critical role in achieving therapeutic efficacy.

The pharmacological potential of 4-(3-Phenylpropoxy)piperidine hydrochloride has not been exhaustively explored, but preliminary data suggest that it may exhibit interactions with various biological targets. For instance, its structural similarity to certain neurotransmitter receptor ligands suggests possible activity at serotonin or dopamine receptors. However, further experimental validation is necessary to confirm these hypotheses and to delineate the compound's mechanism of action.

In addition to its pharmacological relevance, 4-(3-Phenylpropoxy)piperidine hydrochloride has applications in synthetic chemistry as a building block for more complex molecules. Its unique scaffold provides chemists with a platform to develop novel analogs with tailored properties. Techniques such as nucleophilic substitution reactions can be employed to introduce additional functional groups, expanding the compound's utility in drug discovery pipelines.

The synthesis of 4-(3-Phenylpropoxy)piperidine hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Key steps typically include the formation of the N-O bond between the piperidine nitrogen and the propoxy group, followed by salt formation with hydrochloric acid. Advances in catalytic methods have improved the efficiency of these transformations, making large-scale production more feasible.

From an industrial perspective, the demand for high-quality intermediates like 4-(3-Phenylpropoxy)piperidine hydrochloride continues to grow as pharmaceutical companies seek innovative solutions for drug development. Its role as a versatile building block positions it as a valuable asset in synthetic chemistry libraries, supporting both academic research and industrial applications.

The future direction of research on 4-(3-Phenylpropoxy)piperidine hydrochloride may include exploring its derivatives for therapeutic purposes. By modifying key structural features, researchers can fine-tune its pharmacological profile to target specific diseases or conditions. Collaborative efforts between chemists and biologists will be essential in translating these findings into clinical applications.

In conclusion,4-(3-Phenylpropoxy)piperidine hydrochloride (CAS No. 745066-62-0) represents a promising compound with significant potential in pharmaceutical research and development. Its unique structure, solubility advantages, and synthetic versatility make it an attractive candidate for further exploration. As our understanding of drug design principles continues to evolve,4-(3-Phenylpropoxy)piperidine hydrochloride may play a crucial role in discovering new treatments for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)